Discovery of a novel Wnt inhibitor DK419: Reversing temozolomide resistance in glioblastoma by switching off Wnt/β-catenin signaling pathway to inhibit MGMT expression

Temozolomide Reversing
DOI: 10.1016/j.ejmech.2025.117411 Publication Date: 2025-02-17T16:52:05Z